Unimed Assis starts offering coverage for the quick test of COVID-19 – Assiscity

0
5


According to the new rules established by the National Supplementary Health Agency (ANS), Unimed Assis now offers coverage for COVID-19 tests. The decision came into force on June 29, 2020 and requires the beneficiary’s attention to the guidelines for the examination.

In order for the beneficiary to be able to perform the exam through the health plan, it will be necessary to present the medical prescription that recommends the need for the test and, like the other laboratory exams, request the release of the guide in the operator’s service sector or by WhatsApp (18 ) 99723-6795. According to the Unimed Assis Care and Health Care Center Manager, Tatiana Gomes Funari, the beneficiary must be symptomatic, that is, diagnosed by a doctor and referred for examination.

The serological examination detects the presence of antibodies (IgA, IgG or IgM) produced by the organism after exposure to the virus that causes Covid-19.

Disclosure
Unimed Assis reinforces that, in order for the beneficiary to be able to perform the examination under the health plan, it will be necessary to present the medical prescription that recommends the need for the test

“According to ANS, the rapid test will have the coverage of the health plan in cases where the patient has or has had symptoms consistent with the flu syndrome or the severe acute respiratory syndrome”, explains Tatiana.

Symptoms of the Flu Syndrome are considered to be acute respiratory symptoms, characterized by feverish sensation or fever, accompanied by cough or sore throat, or runny nose, or difficulty breathing. In the cases of Severe Acute Respiratory Syndrome, it has symptoms such as respiratory distress or difficulty breathing, or persistent pressure in the chest, or oxygen saturation less than 95% in room air, or bluish coloring of the lips or face.



Source link
https://www.assiscity.com/saude/unimed-assis-passa-a-oferecer-cobertura-para-teste-rapido-de-covid-19-100614.html

LEAVE A REPLY

Please enter your comment!
Please enter your name here